Russell Investments Group’s Niagen Bioscience NAGE Stock Holding History

Russell Investments Group’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.4K	Sell	4,632 -32,362	-87%	-$175K	﹤0.01%	3618
2025 Q4	$235K	Buy	36,994 +726	+2%	+$5.05K	﹤0.01%	2783
2025 Q3	$338K	Buy	36,268 +14,518	+67%	+$147K	﹤0.01%	2626
2025 Q2	$313K	Buy	21,750 +4,341	+25%	+$42.9K	﹤0.01%	2507
2025 Q1	$120K	Buy	+17,409	New	+$109K	﹤0.01%	2716
2021 Q3	–	Sell	-37,026	Closed	-$365K	–	3245
2021 Q2	$365K	Buy	+37,026	New	+$323K	﹤0.01%	2713

Other funds holding NAGE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Russell Investments Group's NAGE Position: Q1 2026 in Review

Russell Investments Group reduced its Niagen Bioscience (NAGE) stake by 87% in Q1 2026, selling an estimated $175K and leaving 4,632 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3618.

Russell Investments Group first reported a position in NAGE in Q2 2021 and has held it in 6 quarters since. The position peaked at $365K in Q2 2021. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

Russell Investments Group held 4,632 shares of Niagen Bioscience worth $20.4K as of Q1 2026.
Russell Investments Group sold 32,362 Niagen Bioscience shares in Q1 2026, an estimated $175K.
Niagen Bioscience made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3618 holding.
Russell Investments Group first reported a position in Niagen Bioscience in Q2 2021 and has held it in 6 quarters since.
Russell Investments Group's Niagen Bioscience position peaked at $365K in Q2 2021.
143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.